MarketPulse

fund holdings

2 articles
The Motley FoolThe Motley Fool··Seena Hassouna

Specialist Biotech Fund's $25.8M Spyre Bet Signals Confidence in Preclinical Pipeline

VR Adviser increased Spyre Therapeutics stake by 1M shares to $120.74M. Stock surged 132% annually, but preclinical risks remain high for retail investors.
SYREbiotech investmentmonoclonal antibodies
The Motley FoolThe Motley Fool··Jonathan Ponciano

Sophron Capital Trims Grocery REIT Position as $PECO Outperforms

Sophron Capital sold $7M worth of Phillips Edison shares in Q4, reducing stake from 6.1% to 4.2%, signaling portfolio rebalancing rather than confidence loss.
PECOportfolio rebalancingREIT